PREVYMIS Merck Sharp & Dohme (Australia) Pty Ltd
Product name
PREVYMIS
Accepted date
Jan-2024
Active ingredients
letermovir
Proposed indication
CMV Prophylaxis in Kidney Transplant Recipients
Application type
C (new indication)
Publication date
Jan-2024